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for ABCA4 p.Arg602Trp missense mutation in a
pediatric patient with rapidly progressive
retinal dystrophy
Maria Carolina Ortube1*, Samuel P Strom2,3, Stanley F Nelson2,3, Steven Nusinowitz1, Ariadna Martinez1
and Michael B Gorin1,3Abstract
Background: A pediatric patient presented with rapidly progressive vision loss, nyctalopia and retinal dystrophy.
This is the first report of homozygosity for the p.Arg602Trp mutation in the ABCA4 gene. The child became legally
blind within a period of 2 years.
Case presentation: An eight year-old Hispanic female presented with bilateral decreased vision following a febrile
gastrointestinal illness with nausea and vomiting. Extensive workup involved pediatric infectious disease and
rheumatology consultations.
Initial visual acuity was 20/60 at distance and 20/30 at near in both eyes. Rapidly progressive vision loss occurred
during a 2-year period resulting in visual acuities of 20/200 at distance in both eyes. Fundus exam disclosed
attenuated vessels and multiple subretinal blister-like elevations. Optical coherence tomography showed far
more lesions than were clinically evident with different levels of elevation. Autofluorescence imagery showed
dramatic and widespread geographic areas of atrophy. The deposits that appeared drusen-like on clinical exam were
hyperfluorescent, consistent with lipofuscin deposits containing A2e (N-retinylidene-N-retinylethanolamine) indicative
of RPE cell dysfunction. Electroretinography was consistent with cone dystrophy, with relative preservation of rod
function. Blood analysis and rheumatology evaluation found no evidence of a diffuse post-infectious/inflammatory
process. The unique and rapid progression of her subretinal blister-like lesions was documented by fluorescein
angiography, optical coherence tomography, autofluorescence imagery, and fundus photography. Family pedigree
history disclosed consanguinity, her parents being first cousins. DNA analysis by whole exomic sequencing revealed
homozygosity of p.Arg602Trp in the ABCA4 gene.
Conclusion: The pediatric patient presented with a striking clinical appearance and dramatic rate of progression that
was clinically more characteristic of an infectious or inflammatory process. This case expands the diverse range of
phenotypes attributed to ABCA4 mutations and further supports the role of whole exome sequencing as a powerful
new tool available to aid clinicians in establishing diagnosis for challenging cases.
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ABCA4 related retinopathies include an interesting diver-
sity of common and unusual retinal phenotypes [1]. Muta-
tions in the ABCA4 gene have been linked to several
conditions such as autosomal recessive retinitis pigmentosa
(arRP) [2], autosomal recessive Stargardt disease (arSTGD),
autosomal recessive cone-rod dystrophy (arCRD) [3],
bull’s eye maculopathy [4], and age-related macular
degeneration [5,6].
Stargardt disease is the most common hereditary
macular dystrophy, affecting children with a prevalence
of 1:10.000, as described by September et al. [7].
In this report we present a case of early onset and dra-
matic vision loss progression in a child who underwent
multiple ophthalmological and systemic procedures in
order to rule out neoplastic, inflammatory or infectious
etiologies. After 2 years of ophthalmic follow-up we per-
formed exomic sequencing and identified a likely patho-
genic homozygous variant in ABCA4 (p.Arg602Trp).
This variant has been reported previously in homozygous
form but, except for age of onset, the phenotype associ-
ated with this variant is not well described [7,8].
Here we provide a comprehensive phenotypic characterization
of a young patient homozygous for this highly pathogenic
p.Arg602Trp variant.
Case presentation
Materials and methods
The study was carried out with approval of UCLA Institu-
tional Review Board (IRB) and the study was conducted
in accordance with regulations of the Health Insurance
Portability and Accountability Act of 1996 (HIPAA).
The proband and her parents enrolled in the Genetics
research study and signed a consent form. The UCLA
HIPAA consent form signed by her parents specifies the
use of the information for publications and research
presentations.
Retrospective case report: An eight year-old Hispanic fe-
male presented with bilateral decreased vision that was
detected one month after an acute febrile gastrointestinal
illness. Initial extensive workup involved pediatric infec-
tology, rheumatology and ophthalmology consultations.
Ophthalmic diagnostics
Fundus photography and fluorescein angiography were
obtained with ultra wide-field Scanning laser ophthal-
moscopy (SLO) (Optos P200C).
Retinal structure was documented by spectral domain
optical coherence tomography (sdOCT) using an ex-
tended 25-degree macular cube with 25 slices (Spectralis,
Heidelberg Engineering, Heidelberg, Germany).
Full-field ERGs were recorded in standardized fashion
[9] from both eyes after pupil dilation as previously de-
scribed [10,11].Autofluorescence & infrared imagery was obtained
with HRAII (30 & 55 degree field of views) (Heidelberg
Engineering) as previously described [12].
Humphrey visual field testing was performed with
24–2 full threshold or SITA [Swedish Interactive Thresh-
olding Algorithm] standard program (Carl Zeiss Meditec).
Central color vision was assessed with the Farnsworth
saturated D-15 and the Ishihara Pseudo-Isochromatic color
plates presented under appropriate lighting conditions.
Genetic testing
The patient underwent genetic testing for VMD2 gene
in order to rule out Best disease.
Whole exome sequencing data acquisition
Standardized protocols were used to generate whole ex-
ome sequencing (WES) data, as follows. Randomly frag-
mented genomic DNA libraries were created following
standard protocols for high-throughput paired-end se-
quencing on the HiSeq2000 instrument (Illumina Inc.,
San Diego, CA). The Agilent SureSelect 50Mb capture
kit was used to enrich the libraries for known coding
loci in the human genome (Agilent Technologies; Santa
Clara, CA). This kit has been shown to effectively cap-
ture >90% of these loci when an adequate average read
depth is reached [13].
Whole Exome Sequencing (WES) data analysis
Nucleotide base calling and quality score assessment was
performed using instrument-specific Real Time Analysis
(RTA) software provided by Illumina. A combination of
commercially or academically available tools and custom
scripts were used to analyze the raw DNA sequence reads.
Alignment to the human genome (hg19; NCBI build 37;
Feb. 2009) was performed using Novoalign V2.07.15b
(Novocraft Technologies; Selangor, Malaysia). Merging,
sorting, and other manipulation of aligned data was per-
formed using SAMTools [14]. PCR clonal duplicate re-
moval was performed using Picard -tools-1.42 (freeware)
[http://picard.sourceforge.net]. Quality score recalibration,
genotyping, variant filtration, and coverage depth ana-
lysis were performed using the Genome Analysis Toolkit
(GATK v1.1) [15].
Variant consequence analysis was performed using
SeattleSeq v7.0 (University of Washington) [16] which in-
corporates many databases including: “NCBI full genes”,
dbSNP131, and the 1000 Genomes Project.
The following cutoffs were used to identify high-priority
candidate variants: homozygous, Quality Score ≥ 100,
coverage depth ≥ 20, not overlapping a segmental duplica-
tion (USCS Genome Browser Assembly GRCh37), minor
allele frequency < 0.01 (dbSNP135). A custom PERL script
was used to search for runs of homozygosity. A run of
homozygosity was defined here as any interval larger than
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all non-reference single nucleotide variants (SNVs) were
homozygous. Familial cosegregation analysis was used.
Results
The vision loss was detected one month after an acute
gastrointestinal illness with high fever, headaches, nausea
and vomiting that required emergency room consult-
ation. The child developed acute symptoms after ingesting
poultry imported from El Salvador, creating the initial sus-
picion of gastrointestinal infection. Bilateral uncorrected
visual acuity was 20/50 at distance and 20/25 at near. Vis-
ual fields showed scattered scotomas in both eyes with
central vision loss in an ill-defined pattern consistent with
retinal dysfunction. A review of prior fundus exam images
showed focal heterogeneous pigmentary changes in the
superotemporal region in both eyes. Electroretinography
testing performed at 4 months after initial consultation
showed severely decreased amplitude and delayed implicit
time for cone function, with relative preservation of rod
function.
Farnsworth D-15 color testing was abnormal for both
eyes, the errors were distributed around the spectrum
with a suggestion of a tritan axis. Only two of the 24
Ishihara color plates were identified correctly with the
right eye and only three with the left eye. Sagittal and
axial contrast brain magnetic resonance imaging was
within normal limits.
The child was referred to UCLA for a third opinion
consultation 6 months after the onset of vision loss and
nyctalopia. Family history was significant for first cousin
consanguinity between the child’s parents, but there was
no family history of blindness. Bilateral distance visual
acuity was 20/60, improving to 20/50 by pinhole. Bilat-
eral near visual acuity was 20/30.
Cycloplegic retinoscopy detected very mild hyperopia
and astigmatism in both eyes (OD: + 1.00 sphere + 1.00
cylinder axis 110 degrees; OS: + 0.75 sphere + 0.50 cylin-
der axis 60 degrees). There was no afferent pupillary de-
fect. Ocular versions and saccadic movements were full
and the child was orthotropic at distance and near.
Stereopsis was 3000 arc seconds (Titmus test).
Anterior segment exam was unremarkable. The vitre-
ous was clear without cells.
Fundus exam disclosed attenuated vessels in all quad-
rants and multiple scattered cysts or “blister-like” subret-
inal elevations, more evident in the posterior pole, with
extensive geographic areas of pigment epithelial deposits.
Cup to disc ratio was 0.6 in both eyes. The foveal reflex
was relatively normal in the right eye and decreased in the
left eye.
55 degrees autofluorescence imagery performed at 6
months after initial consultation (see Figure 1A: Right
eye/C: Left eye) showed dramatic and widespread regionsof both hyperfluorescence and hypofluorescence. The de-
posits that appeared drusen-like on clinical exam were
hyperfluorescent, consistent with lipofuscin deposits con-
taining A2E (N-retinylidene-N-retinylethanolamine) indi-
cative of RPE cell dysfunction [12].
The OCT images revealed numerous subretinal “Blister-
like” lesions with different levels of elevation through-
out the posterior pole (see Figure 1B, right eye and D:
left eye).
Rheumatology evaluation found no evidence of a dif-
fuse post-infectious/inflammatory process. Blood testing
was negative for bacteria, parasites or virus except for
cytomegalovirus (Positive IgG, negative IgM).
The patient experienced rapidly progressive vision loss
during a 2-year period with visual acuities reduced to 20/200
at distance in both eyes from 20/50 at first testing.
The unique and rapid centrifugal progression of her
subretinal blister-like lesions and fibrotic scarring was
documented by fundus photography, OCT, autofluores-
cence and fluorescein angiography.
Figure 2 describes the fluorescein angiography com-
parison at initial consultation (A, right eye and C, left
eye) and 14 months later (B, right eye and D, left eye).
Initially, the subretinal lesions appeared hyperfluorescent
on fluorescein angiography test with a dark choroid im-
pression. There was a marked progression in the number
and size of hyperfluorescent lesions, but there was no
extravasation in the late phase.
Figure 3 shows the 55 –degrees autofluorescence (AF)
imagery for the right eye (Top panel) and the left eye
(Lower panel) at 6, 10, 17, 25 and 38 months after the
initial consultation. Note the dramatic change in size
and spatial distribution of hyperfluorescent and hypo-
fluorescent lesions (as shown within the boundaries of
ellipses and circles). The reduced AF areas are presumed
to identify regions in transition to areas of GA onset.
Interestingly, there is a bilateral region of hyperfluorescent
“Blister-like” lesions temporal to the fovea at 6 months
after initial consultation that slowly became less apparent
by 38 months.
Figure 4 shows the results of ERG testing 4 months
after the initial consultation and 21-months later. A rep-
resentative age-matched normal ERG is shown in the
right column for comparison.
The ERGs recorded on both visits demonstrated se-
verely truncated and delayed cone responses, worse for
the right eye, with relatively preserved, although ab-
normal rod function. In contrast to the AF imaging
that suggested rapid progression of disease (as described
above), a significant progression of ERG responses was
not apparent.
Near IR AF performed at 38 months after initial con-
sultation showed far more lesions that were clinically evi-
dent by standard AF imagery.
Figure 1 55 degrees autofluorescence (A: Right eye & C: Left eye) and optical coherence tomography (B: Right eye & D: Left eye)
performed 6 months after initial consultation. The OCT scan line location is shown as a green line in the autofluorescence images (A & C).
The deposits that appeared drusen-like on clinical exam were hyperfluorescent on autofluorescence imagery (A & C), indicative of RPE cell
dysfunction. The OCTs revealed numerous subretinal lesions with different levels of elevation throughout the posterior pole. White arrows point
to three “blister” like lesions, as seen by OCT. (B, right eye & D, left eye).
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and the child was using a low vision device to read.
Genetic testing
VMD2 testing for vitelliform macular dystrophy (Best dis-
ease) was negative. Whole exome sequencing identified a
homozygous ABCA4 missense variant (p.Arg602Trp) that
has been identified as a Stargardt Disease mutation [7,8].
Familial cosegregation analysis was used, with both par-
ents being heterozygous carriers.
Homozygosity mapping identified 23 blocks (> 2 Mb)
of autozygosity mapping to ten different chromosomes.
Approximately 208 Mb or ~7% of the genome was lo-
cated within such a block in this individual. One of
the largest blocks mapped to the proximal arm of chromo-
some 1 (1p31.1-p22.1; 74.2 Mb-94.6; ~20.5 Mb in size) and
included ABCA4 at its distal end, among many other
genes. This degree of autozygosity strongly confirmed par-
ental consanguinity at the level of first cousins or closer,
consistent with the family self-report.
Whole exomic sequencing (WES) identified a total of 14
homozygous rare coding variants, including p.Arg602Trp
in ABCA4 (Additional file 1). Targeted loci were coveredon average by 105 independent sequence reads. This level
of coverage exceeds minimum recommendations for re-
cessive disease allele discovery [13].
Variants were not filtered for zygosity. All variants
observed within known retinal disease genes were subject
to interpretation. No other variants or sets of variants were
identified which were consistent with a genetic disorder
(e.g. compound heterozygous or homozygous variants in
recessive genes or likely causal heterozygous variants in dom-
inant disease genes). The total number of single-nucleotide
variants observed within targeted protein-coding loci
was 20,478 (Qscore ≥Q100). Over 95% of these variants
mapped to common polymorphisms in dbSNP131. A total
of 592 small insertions or deletions (indels) were also
observed. These values are typical for WES experiments.
Compound heterozygous cases that included the p.Arg602Trp
mutation of the ABCA4 gene have been described in early on-
set, autosomal recessive retinitis pigmentosa families [7,8].
This variant has been previously reported in a homozy-
gous state. Given the patient’s unique ocular phenotype,
the age of onset and the phenotypic variability observed in
ABCA4-related disease [4], we conclude that this homozy-
gous variant is likely disease-causing and rapidly progressive.
Figure 2 Fluorescein angiography at initial ophthalmic consultation (Late phase, A: Right eye & C: Left eye). The left eye was initially more
affected than the right eye, showing multiple ill-defined hyperfluorescent lesions (as described within the boundaries of white circles), with a dark
choroid impression. Fluorescein angiography was repeated at UCLA 14 months after initial consultation (Late phase, B: Right eye and D: Left eye).
The angiogram revealed more lesions than were apparent by ophthalmoscopy. There was a marked progression in the number and size of the
hyperfluorescent subretinal lesions and fibrotic scarring in the posterior pole and peripheral retina (As shown within the boundaries of red circles
& ellipses to describe new lesions; white circles describe the old lesions for comparison). There was no extravasation of the dye in the late phase.
Figure 3 (55 degrees version). 55 degrees Autofluorescence (AF) imagery for the right eye (Top panel) and the left eye (Lower panel) at 6 (A, F), 10
(B, G), 17 (C, H), 25 (D, I) and 38 months (E, J) after initial consultation. Note the dramatic change of size and spatial distribution of hyperfluorescent and
hypofluorescent lesions (as shown within the boundaries of ellipses). The reduced AF areas are presumed to identify regions in transition to geographic
atrophy onset. Note that the bilateral hyperfluorescent lesions temporal to the fovea at 6 months after initial consultation (A & F) are much less apparent
by 38 months (E & J).
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Figure 4 Shows the normal electroretinogram (ERG) responses for a child at this age and the ERG responses obtained at 4 months and
25 months after initial consultation. The ERG is consistent with a modest decrease in both rod and cone mediated retinal function over the
course of 21 months.
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In children, it is important to consider genetic etiologies
in the presence of unusual phenotypes with sudden onset
vision loss. In our clinical report, the combination of ocu-
lar history, fundus imaging and electroretinography led toa diagnosis of a rapidly progressive retinopathy in a young
patient with a severe ABCA4 homozygous variant.
In a case of rapidly progressive retinal degeneration,
Batten disease (neuronal ceroid lipofuscinosis) should be
suspected. Fortunately, the child did not present with
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was required to rule out this diagnosis.
The presence of fibrotic scarring in the paramacular
area [17], the dark choroid, the autofluorescence pheno-
type and the ERG results are consistent with an ABCA4
related retinopathy. The centrifugal expansion of fundus
autofluorescence patterns in Stargardt disease has been
described previously by Cukras et al. [12,18].
All individuals contain a substantial number of poten-
tial disease-causing variants in their DNA and it is not
surprising that an offspring of a consanguineous mating
would be homozygous for several potentially deleterious
recessive alleles. In addition to the aforementioned vari-
ants in ABCA4, this patient also harbored 14 homozy-
gous, rare variants that alter the amino acid sequences
of the encoded proteins (Additional file 1). The extent to
which these and other heterozygous genetic variants
contribute to the systemic and ophthalmic clinical well
being of this patient is not discernable at this time.
The value of exome sequencing is crucial in cases
where the phenotype is not suggestive of a particular
candidate gene or set of genes, and this approach allows
one to reasonably address multiple genetic etiologies.
However it is also important to emphasize that, given
the complexity of the data provided by exome sequen-
cing, a careful pedigree, clinical ascertainment of other
family members and the testing of DNA from key family
members is essential for interpreting that data.Additional file
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identified in subject meeting inclusion criteria: Quality Score ≥100,
coverage depth ≥ 20, no overlap with segmental duplications (UCSC
Genome Browser), Minor Allele Frequency <0.01 (dbSNP135). The
putative causal variant in ABCA4 is highlighted in bold. No other variants
are clinically relevant to the patient’s presentation. Abbreviations: Chr,
chromosome; Ref, human genome reference nucleotide; Alt, alternate
allele nucleotide; OMIM, Online Mendelian Inheritance in Man database;
STGD, Stargardt Disease; OMD, Occult Macular Dystrophy; US1D, Usher
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